Assay Development and High-Throughput Screening of Small Molecular c-Abl Kinase Activators
暂无分享,去创建一个
Chad Quinn | R. Ames | G. Hofmann | J. Cottom | Hu Li | K. Johanson | Hong Zhang | Jingsong Yang | Da-Yuan Wang | Robert S Ames | Hu Li | B. Siegfried | T. Yi | T. Ho | C. Quinn | Da-Yuan Wang | Kyung Johanson | Jingsong Yang | Thau F Ho | Josh Cottom | Glenn Hofmann | Brett Siegfried | Hong Zhang | Tracey Yi
[1] R. Bronson,et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.
[2] Bruce A. Roe,et al. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene , 1986, Cell.
[3] E. Sargsyan,et al. AMP-activated protein kinase agonist dose dependently improves function and reduces apoptosis in glucotoxic beta-cells without changing triglyceride levels. , 2008, Journal of molecular endocrinology.
[4] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[5] J. Wang,et al. Abl tyrosine kinase in signal transduction and cell-cycle regulation. , 1993, Current opinion in genetics & development.
[6] L. Serrano,et al. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions. , 1998, Journal of molecular biology.
[7] Oliver Hantschel,et al. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. , 2006, Molecular cell.
[8] R. V. van Etten,et al. c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines* , 2000, The Journal of Biological Chemistry.
[9] B. Viollet,et al. Beyond AICA riboside: In search of new specific AMP‐activated protein kinase activators , 2009, IUBMB life.
[10] R. A. Etten,et al. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain , 2001, Oncogene.
[11] B. Hansen,et al. A-769662 activates AMPK beta1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. , 2009, American journal of physiology. Cell physiology.
[12] Shohei Koide,et al. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain , 2010, Nature Structural &Molecular Biology.
[13] M. Baccarani,et al. Chronic myeloid leukaemia , 2007, The Lancet.
[14] D. Auld,et al. Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection. , 2003, Assay and drug development technologies.
[15] G. Superti-Furga,et al. Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase , 2003, Cell.
[16] Kristin E. D. Coan,et al. Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding , 2009, Journal of medicinal chemistry.
[17] Wolfgang Jahnke,et al. Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site. , 2010, Biochimica et biophysica acta.
[18] D. McDonald,et al. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] N. Narula,et al. Targeting of the c-Abl Tyrosine Kinase to Mitochondria in Endoplasmic Reticulum Stress-Induced Apoptosis , 2001, Molecular and Cellular Biology.
[20] B. Viollet,et al. Targeting the AMPK pathway for the treatment of Type 2 diabetes. , 2009, Frontiers in bioscience.
[21] Arthur Christopoulos,et al. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders , 2009, Nature Reviews Drug Discovery.
[22] J. Mestan,et al. Binding or bending: distinction of allosteric Abl kinase agonists from antagonists by an NMR-based conformational assay. , 2010, Journal of the American Chemical Society.
[23] S. Goff,et al. Mice homozygous for the abl m1 mutation show poor viability and depletion of selected B and T cell populations , 1991, Cell.
[24] G. Neubauer,et al. Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase , 2001, Oncogene.
[25] R. Ames,et al. Gene expression in mammalian cells using BacMam, a modified baculovirus system. , 2007, Methods in molecular biology.
[26] Yoshiaki Washio,et al. Direct small-molecule kinase activation: Novel approaches for a new era of drug discovery. , 2009, Current opinion in drug discovery & development.
[27] D. Wasilko,et al. The titerless infected-cells preservation and scale-up (TIPS) method for large-scale production of NO-sensitive human soluble guanylate cyclase (sGC) from insect cells infected with recombinant baculovirus. , 2009, Protein expression and purification.
[28] C. Hudis,et al. A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer , 2005, Breast Cancer Research and Treatment.
[29] William P Schiemann,et al. Activated Abl kinase inhibits oncogenic transforming growth factor‐β signaling and tumorigenesis in mammary tumors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] Xuefei Gao,et al. Inhibitory effects of A-769662, a novel activator of AMP-activated protein kinase, on 3T3-L1 adipogenesis. , 2009, Biological & pharmaceutical bulletin.
[31] D. Baltimore,et al. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.
[32] J. Mestan,et al. Allosteric inhibitors of Bcr-abl–dependent cell proliferation , 2006, Nature chemical biology.
[33] G. Superti-Furga,et al. A Myristoyl/Phosphotyrosine Switch Regulates c-Abl , 2003, Cell.
[34] L. Kifle,et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. , 2006, Cell metabolism.
[35] James Inglese,et al. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. , 2010, Current opinion in chemical biology.
[36] R. A. Etten. Cycling, stressed-out and nervous: cellular functions of c-Abl , 1999 .